DE19534519A1
(en)
*
|
1995-09-05 |
1997-07-10 |
Desitin Arzneimittel Gmbh |
Sugar or sugar alcohols for use as an anti-epileptic
|
WO2010046726A1
(en)
|
2008-10-20 |
2010-04-29 |
Chemyunion Química Ltda. |
Xylitol esters and ethers applied as alternative emulsifiers, solvents, co-emulsifiers and preservative systems for pharmaceutical and cosmetic products
|
WO2014037832A2
(en)
*
|
2012-09-06 |
2014-03-13 |
Mahesh Kandula |
Compositions and methods for the treatment of epilepsy and neurological diseases
|
CA2872975A1
(en)
|
2012-05-07 |
2013-11-14 |
Cellixbio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
AU2013257742A1
(en)
|
2012-05-07 |
2014-11-27 |
Cellixbio Private Limited |
Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
|
US9399634B2
(en)
|
2012-05-07 |
2016-07-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of depression
|
WO2013167991A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of metabolic disorders
|
WO2013168025A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for treatment of blood clotting disorders
|
US9434704B2
(en)
|
2012-05-08 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological degenerative disorders
|
WO2013167992A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of inflammatory disorders
|
US9266823B2
(en)
|
2012-05-08 |
2016-02-23 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of parkinson's disease
|
US9394288B2
(en)
|
2012-05-10 |
2016-07-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of asthma and allergy
|
US9573927B2
(en)
|
2012-05-10 |
2017-02-21 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of severe pain
|
WO2013168004A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of fibromyalgia pain
|
WO2013168002A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological conditions
|
US9315478B2
(en)
|
2012-05-10 |
2016-04-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
WO2013168011A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of chronic pain
|
WO2013168001A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
US9499527B2
(en)
|
2012-05-10 |
2016-11-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of familial amyloid polyneuropathy
|
WO2013168033A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for treatment of neurologic diseases
|
US9339484B2
(en)
|
2012-05-10 |
2016-05-17 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
|
US9242939B2
(en)
|
2012-05-10 |
2016-01-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of respiratory disorders
|
WO2013167999A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurologic diseases
|
SG11201407318UA
(en)
|
2012-05-10 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of metabolic syndrome
|
CA2873096A1
(en)
|
2012-05-23 |
2013-11-28 |
Cellixbio Private Limited |
Compositions and methods for the treatment of inflammatory bowel disease
|
JP2015518855A
(en)
|
2012-05-23 |
2015-07-06 |
セリックスビオ プライヴェート リミテッド |
Compositions and methods for the treatment of mucositis
|
US9492409B2
(en)
|
2012-05-23 |
2016-11-15 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
SG11201407322QA
(en)
|
2012-05-23 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of multiple sclerosis
|
US9227974B2
(en)
|
2012-05-23 |
2016-01-05 |
Cellex Bio Private Limited |
Compositions and methods for the treatment of respiratory disorders
|
US9434729B2
(en)
|
2012-05-23 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
|
US9108942B1
(en)
|
2014-11-05 |
2015-08-18 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
US9187427B2
(en)
|
2012-08-03 |
2015-11-17 |
Cellix Bio Private Limited |
N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
|
US9624168B2
(en)
|
2012-09-06 |
2017-04-18 |
Cellix Bio Private Limited |
Compositions and methods for the treatment inflammation and lipid disorders
|
SG11201407325YA
(en)
|
2012-09-08 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for treatment of inflammation and lipid disorders
|
US9333187B1
(en)
|
2013-05-15 |
2016-05-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory bowel disease
|
CA2914461A1
(en)
|
2013-06-04 |
2014-12-11 |
Cellixbio Private Limited |
Compositions and methods for the treatment of diabetes and pre-diabetes
|
WO2016110865A1
(en)
|
2015-01-06 |
2016-07-14 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammation and pain
|
US9096537B1
(en)
|
2014-12-31 |
2015-08-04 |
Mahesh Kandula |
Compositions and methods for the treatment of mucositis
|
WO2016046835A1
(en)
|
2014-09-26 |
2016-03-31 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy and neurological disorders
|
CN107207403A
(en)
|
2014-09-29 |
2017-09-26 |
塞尔利克斯生物私人有限公司 |
Composition and method for treating multiple sclerosis
|
SG11201703369WA
(en)
|
2014-10-27 |
2017-05-30 |
Cellix Bio Private Ltd |
Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
|
US10208014B2
(en)
|
2014-11-05 |
2019-02-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
US9290486B1
(en)
|
2014-11-05 |
2016-03-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy
|
US9284287B1
(en)
|
2014-11-05 |
2016-03-15 |
Cellix Bio Private Limited |
Compositions and methods for the suppression of carbonic anhydrase activity
|
US9175008B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Prodrugs of anti-platelet agents
|
US9321716B1
(en)
|
2014-11-05 |
2016-04-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
US9150557B1
(en)
|
2014-11-05 |
2015-10-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of hyperglycemia
|
US9173877B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
US9932294B2
(en)
|
2014-12-01 |
2018-04-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
US9206111B1
(en)
|
2014-12-17 |
2015-12-08 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological diseases
|